Docmode Health TechnologiesShare price, financial results, shareholding and management
- Market cap
- ₹7 cr
- Stock P/E
- -peers 22.4
- Book value
- ₹26.1
- Price to book
- 0.81
- EV / operating profit
- -
- Market cap to sales
- 0.26
- ROCE · FY26
- 6.0%
- ROE · FY26
- -1.7%
- ROE, 3-year average
- -6.9%
- Operating margin · FY26
- -1.3%peers 27.7%
- Sales growth, 3 years
- -8.1%
- Profit growth, 3 years
- -
- Debt to equity
- 0.45peers 0.15
- Borrowings
- ₹3.7 cr
- Interest cover
- 0.9×
- Cash from business / op. profit
- -1265%
- Debtor days
- 106
- Pledged
- 22.05%
- Promoter holding
- 29.50%
- Change in promoter holding
- -1.36 pts
- Shareholders
- 195
- 52-week high / low
- ₹121 / ₹21
- Dividend yield
- 0.00%
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
Docmode Health Technologies share price chart
Close on 4 Nov 2026 · -3.85% on the day · Vol 5,600
Daily prices to 4 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 4 Nov 2026
- 1 month
- -14.3%
- 3 months
- -34.3%
- 6 months
- -51.9%
- 1 year
- -82.0%
- Since IPO
- -73.2%
- Traded a day, 20 days
- ₹0.08 cr
- Taken for delivery
- 84%
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | -39% | - |
| 3 years, a year | -8% | - |
| Latest half, H2 FY26 | -64% | - |
About Docmode Health Technologies: business, products and customers
Docmode Health Technologies, now renamed Doctrack Solutions, runs online and in-person courses, surveys and research programmes for doctors, paid for mostly by drug and healthcare companies. Its shares trade on NSE Emerge.
The company runs continuing medical education courses and conferences for doctors, online and in person, along with paid surveys and studies in which registered doctors take part, medical writing and promotional literature for pharmaceutical marketers, clinical research support under its own ethics committee, and an online store of books and event passes. Its main asset, the company says, is its verified network of registered healthcare professionals.
Most of what it bills is bought in: purchases of goods and services were close to two thirds of FY26 revenue, so margins are thin and revenue swings with the size of the programmes it runs. In FY26 it handed most of its selling to resellers and distributors; on business sold through a partner it books only its own share, so reported revenue falls even when the work is the same, while fixed selling costs come down. Management also stopped taking engagements below its margin thresholds and is reviewing the online portal business, including selling parts of it.
Read more about the business
The year also brought strain on the balance sheet: the company defaulted on non-convertible debentures, the lenders enforced shares the promoters had pledged, and the auditors qualified their opinion on the FY26 accounts. Most of the money customers owe is more than two years old.
From the Annual Reports 2025-26 and 2024-25 and the company's announcements of April and October 2026. No offer document text was on file to read.
Read the deeper study ↓In its favour
- Nothing stands out on these rules this year.
To watch
- Confirmation from the debenture trustee or holders that the enforced shares settle the debenture default (Annual Report 2025-26, p.26).
- Collection of the receivables that are two to three years old (Annual Report 2025-26, p.81).
- Any sale or partner deal for the online portal business, which the company says is under review (Annual Report 2025-26, p.5).
- Whether the company returns to an operating profit, which the Chairman calls the measure the board expects to be judged by (Annual Report 2025-26, p.9).
- Customers take longer to pay than before: 106 days in FY26, against 1 in FY20.
From the company's documents first, then the reported figures read by fixed rules, the same for every company. Facts, not a view on the shares.
Docmode Health Technologies revenue and profit growth
Half-yearly results · Profit and lossSales have fallen.
SME companies report every six months. In the latest half, sales were lower than in the same half a year before.
Docmode Health Technologies half-yearly results
SME companies report every six months · ₹ crore
| H2FY23 | H1FY24 | H2FY24 | H1FY25 | H2FY25 | H1FY26 | H2FY26 | |
|---|---|---|---|---|---|---|---|
| Sales | 20.02 | 23.60 | 16.40 | 20.42 | 21.35 | 17.85 | 7.67 |
| Expenses | 18.58 | 20.88 | 17.23 | 20.54 | 21.91 | 17.05 | 8.82 |
| Operating profit | 1.44 | 2.72 | -0.83 | -0.12 | -0.55 | 0.80 | -1.16 |
| OPM | 7.2% | 11.5% | -5.1% | -0.6% | -2.6% | 4.5% | -15.1% |
| Interest | 0.72 | 0.84 | 0.82 | 1.09 | 0.83 | 0.85 | 0.11 |
| Depreciation | 0.01 | 0.02 | 0.01 | 0.14 | 0.16 | 0.11 | 0.12 |
| Profit before tax | 0.76 | 1.92 | -1.59 | -0.51 | -1.45 | -0.09 | -0.07 |
| Net profit | 0.61 | 1.36 | -1.17 | -0.52 | -1.38 | -0.09 | -0.07 |
Docmode Health Technologies profit and loss
Full years to March, FY20 to FY26 · ₹ crore, consolidated where reported
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Sales | 6.94 | 7.10 | 12.42 | 32.88 | 39.93 | 41.77 | 25.52 |
| Expenses | 6.55 | 6.23 | 10.53 | 29.14 | 38.05 | 42.45 | 25.85 |
| Operating profit | 0.39 | 0.87 | 1.89 | 3.74 | 1.88 | -0.68 | -0.34 |
| OPM | 5.6% | 12.3% | 15.2% | 11.4% | 4.7% | -1.6% | -1.3% |
| Other income | 0 | 0 | 0.01 | 0.10 | 0.14 | 0.93 | 1.40 |
| Interest | 0.01 | 0.19 | 0.38 | 1.13 | 1.66 | 1.92 | 0.96 |
| Depreciation | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.30 | 0.23 |
| Profit before tax | 0.33 | 0.64 | 1.50 | 2.69 | 0.34 | -1.97 | -0.14 |
| Tax rate | -6.1% | 14.1% | 38.7% | 27.5% | 44.1% | -3.1% | 0.0% |
| Net profit | 0.34 | 0.55 | 0.92 | 1.95 | 0.19 | -2.03 | -0.14 |
| EPS ₹ | · | · | · | 8.50 | 0.60 | -6.45 | -0.43 |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
A tax rate above 60% or below zero (FY20, FY25) comes from tax charged on a small or negative profit, as reported.
Earnings per share before FY24 is on the share count of that time, before later bonus or share issues, so it does not compare with the years after.
Docmode Health Technologies profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. Its costs were more than its sales. It earns a low return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Operating margin | 5.6% | 12.3% | 15.2% | 11.4% | 4.7% | -1.6% | -1.3% |
| Tax rate | -6.1% | 14.1% | 38.7% | 27.5% | 44.1% | -3.1% | 0.0% |
| ROCE | · | 113.7% | 48.5% | 42.0% | 12.7% | -0.3% | 6.0% |
| ROE | · | · | 98.9% | 80.2% | 2.7% | -21.7% | -1.7% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Docmode Health Technologies debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has shrunk. It cut its borrowings last year. Its loans are smaller than its own money. Last year the business brought in more cash than it showed as profit. Customers take about as long to pay as they did in FY24.
Bars below the line are cash going out.
Docmode Health Technologies balance sheet
At each 31 March · ₹ crore
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.01 | 0.01 | 0.01 | 2.29 | 3.14 | 3.14 | 3.14 |
| Reserves | -0.10 | 0.46 | 1.38 | 1.18 | 7.23 | 5.21 | 5.07 |
| Net worth | -0.09 | 0.47 | 1.39 | 3.47 | 10.37 | 8.35 | 8.21 |
| Borrowings | 0.02 | 1.06 | 4.84 | 8.48 | 9.18 | 6.82 | 3.73 |
| Other liabilities | 1.96 | 4.14 | 3.85 | 5.06 | 10.60 | 24.14 | 21.56 |
| Total liabilities | 1.89 | 5.67 | 10.08 | 17.01 | 30.15 | 39.31 | 33.50 |
| Fixed assets | 0.15 | 0.16 | 0.50 | 2.07 | 0.97 | 1.22 | 0.98 |
| Capital work in progress | 0 | 0 | 0 | 0 | 8.50 | 11.60 | 13.48 |
| Investments | 0 | 0.10 | 1.25 | 1.20 | 1.26 | 1.29 | 1.30 |
| Other assets | 1.74 | 5.41 | 8.33 | 13.74 | 19.42 | 25.20 | 17.74 |
| Receivables | · | · | · | · | · | 9.24 | 7.44 |
| Inventory | · | · | · | · | · | 11.17 | 7.75 |
| Cash | · | · | · | · | · | 1.84 | 0.18 |
| Trade payables | · | · | · | · | · | 5.34 | 3.52 |
Docmode Health Technologies cash flow
₹ crore
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | 0.17 | -0.50 | -2.05 | -0.83 | 4.51 | 6.68 | 4.30 |
| Cash from investing | -0.20 | -0.13 | -1.52 | -1.57 | -7.55 | -3.67 | -1.89 |
| Cash from financing | 0.01 | 0.84 | 3.41 | 2.65 | 5.76 | -4.28 | -4.06 |
| Net cash flow | -0.02 | 0.21 | -0.16 | 0.25 | 2.72 | -1.27 | -1.65 |
| Capital spending | · | · | · | · | · | 0 | 0 |
Working capital
Days
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 1 | 70 | 112 | 92 | 105 | 81 | 106 |
| Inventory days | 121 | 669 | 501 | · | · | · | 634 |
| Days payable | 60 | 512 | 323 | · | · | · | 288 |
| Cash conversion cycle | 61 | 227 | 291 | 92 | 105 | 81 | 453 |
| Working capital days | -23 | 30 | 92 | 50 | 12 | -54 | -96 |
Docmode Health Technologies peers and competitors
Listed SME companies in the same industryBy sales, Docmode Health Technologies is number 14 of the 22 listed SME companies in other consumer services.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Mopshop Distribution | - | - | 44.1 | 5.2 | 18.1% | 1.02 |
| Drone Destination | 79 | 67.8 | 35.1 | 1.2 | 27.7% | 0.39 |
| Docmode Health Technologies | 7 | - | 25.5 | -0.1 | -1.3% | 0.45 |
| Flywings Simulator Training Centre | 268 | 23.0 | 24.5 | 11.6 | 64.2% | 0.12 |
| Thinking Hats Entertainment Solutions | 16 | 12.7 | 23.5 | 1.2 | 9.9% | 0.37 |
| Fusion Klassroom Edutech | 155 | 20.4 | 23 | 7.6 | 56.4% | 0.19 |
| Blue Pebble | 26 | 53.2 | 21.6 | 0.5 | 4.5% | 0.00 |
| Moxsh Overseas Educon | 102 | 44.4 | 12.9 | 2.3 | 37.7% | 0.24 |
| Humming Bird Education | 17 | 21.3 | 7.9 | 0.8 | 5.4% | 0.00 |
| Sodhani Academy of Fintech Enablers | 75 | 21.7 | 3.7 | 3.5 | 55.1% | 0.00 |
| Kuberan Global Edu Solutions | 7 | - | 0 | -0.4 | - | 0.05 |
| Median of the 10 others | 75 | 22.4 | 22.3 | 1.8 | 27.7% | 0.15 |
Docmode Health Technologies shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own less than half the company, a little less than in the first filing shown. Big foreign and Indian funds own very little. The number of shareholders has come down.
Docmode Health Technologies shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Feb 24 | Mar 24 | Sep 24 | Dec 24 | Mar 25 | Sep 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|
| Promoters | 47.44% | 47.44% | 47.44% | 47.44% | 47.44% | 30.86% | 29.50% |
| Foreign investors (FIIs) | 0.05% | 0.00% | 0.00% | 0.00% | 0.00% | - | - |
| Indian institutions (DIIs) | 0.20% | 0.00% | 0.00% | 0.00% | 0.00% | - | - |
| HNIs (over ₹2 lakh each) | 25.50% | 28.35% | 34.69% | 35.86% | 34.33% | 51.93% | 53.45% |
| Small holders (up to ₹2 lakh) | 22.32% | 15.65% | 14.56% | 14.20% | 14.64% | 12.78% | 11.86% |
| Companies and others | 4.49% | 8.56% | 3.31% | 2.50% | 3.59% | 4.43% | 5.19% |
| Number of shareholders | 483 | 238 | 259 | 262 | 246 | 221 | 195 |
The named holders are at 31 March 2026, beside 30 Sept 2025, each under the group the pattern files them in.
Docmode Health Technologies study: the business from its own documents
Read from 2 of the company's own documentsDocmode Health Technologies so far
From the company's own record
- 2 Feb 2024Listed on NSE Emerge at ₹79
- 31 March 2026Promoters at 29.50%
- 29 April 2024Highest close since listing, ₹264.80
Docmode Health Technologies key facts from the filings
Each figure with the document it comes from
- FY26 revenue
- ₹25.5 cr
- Down from ₹41.8 cr in FY25, after the move to partner-led selling and the dropping of low-margin work.Annual Report 2025-26, p.4 to 5 and p.67
- Bought-in costs
- ₹16.5 cr
- Purchases of goods and services in FY26, against ₹44.8 cr in FY25, the largest cost by far.Annual Report 2025-26, p.67
- Loss before tax
- ₹0.14 cr
- FY26, narrower than ₹1.97 cr in FY25 after cost cuts.Annual Report 2025-26, p.67
- Debenture default
- ₹2.25 cr
- Non-convertible debentures not repaid; interest of ₹0.30 cr was left out of the accounts, which the auditors qualified.Annual Report 2025-26, p.26
- Promoter shares enforced
- 17.98%
- Pledged shares taken by debenture holders in 2025: 16.57% of the company in June and 1.41% in August.Annual Report 2025-26, p.20; our arithmetic
Show 4 more facts
- Old receivables
- ₹6.7 cr
- Owed for two to three years, out of ₹7.4 cr due from customers at March 2026, with no provision made.Annual Report 2025-26, p.81
- Short-term borrowings
- ₹2.6 cr
- At March 2026, down from ₹5.7 cr; finance costs halved to ₹1.0 cr but management still calls them too high.Annual Report 2025-26, p.66, p.67 and p.10
- Staff costs
- ₹2.7 cr
- FY26 employee costs, down from ₹3.8 cr, as delivery was folded into fewer teams.Annual Report 2025-26, p.67 and p.5
- New name
- Doctrack Solutions
- Approved by shareholders on 8 July 2026 and by the Registrar of Companies on 28 July 2026.Annual Report 2025-26, p.4 and p.21
What the company said, and what happened
The company's own statements, attributed, set against what it later reported; not newboard's estimates
The company says it will add no new products or lines in FY27, will widen partner coverage, keep its lower cost base and margin thresholds, grow repeat directly billed work with drug companies, and turn margins into cash. It says reported revenue may fall further as more work goes through partners, that cutting finance costs is an explicit aim, and that options for the online portal include selling parts of it, with no commitment made.
| What management said | When | What happened |
|---|---|---|
| Sustained growth through FY26 from a strong first quarter | Annual Report 2024-25 | FY26 revenue fell to ₹25.5 cr from ₹41.8 cr |
Is it a good business? Six questions
Each answer is about that one question, read from the documents; tap one for the evidence. Not a view on the shares.
The company earns a thin cut on medical education and research programmes that drug companies pay for, much of it passed through to outside suppliers.
Its weak spots are falling sales, a debt default that cost the founders a large part of their shares, and very old money owed by customers.
WatchCan it set its own prices?It is now turning away work below its margin thresholds, but most of its costs are bought in and its own margin is thin.
AverageHow strong is it against rivals?A verified doctor network and compliance credentials help it stay on drug companies' approved lists, though no rivals are named.
AverageWho are its customers?Repeat drug and healthcare companies pay for most of the work, now partly reached through resellers.
WatchDoes it need a lot of money?It needs little plant, but slow collections and costly borrowing have strained it, ending in a debenture default.
WatchCan it keep finding new work?It has stopped adding products and is leaning on partners and existing clients, while sales fell sharply in the latest year.
WatchDo good and bad years swing a lot?Revenue depends on the number and size of programmes clients fund, and it has swung widely from half to half.
Who runs Docmode Health Technologies?
Promoters, directors and officers; tap a name for the background
PPPaulson Paul ThazhathedathFounder, Promoter, Chairman and Whole-Time Director · holds 16.37%
Has more than fifteen years in mass media and advertising and has shaped the company's strategic direction. Lost part of the pledged shareholding when debenture holders enforced their pledge in 2025.
Annual Report 2025-26, p.13, p.14 and p.20HAHans Albert LewisFounder, Promoter, Whole-Time Director and Chief Financial Officer · holds 13.07%
A graduate in mass media and advertising from Wilson College, Mumbai (2004), with more than fifteen years in mass media and advertising; runs financial management and operations.
Annual Report 2025-26, p.13 and p.14PJParesh Jaysih SampatManaging Director
A cost accountant (FCMA), Fellow Company Secretary and CIMA (London) qualified management accountant with law and commerce degrees from Mumbai University; experienced in fund raising, public issues, capital structuring and compliance. Managing Director since 30 September 2024 and a common director in related companies Aumen Healthcare, Augmentors Healthcare and Chemolec Enterprises.
Annual Report 2025-26, p.13 and p.133; Annual Report 2024-25, p.19MEMonina Elizabeth LewisNon-Executive Director
Holds a Bachelor of Science from Mumbai University (2001) and has six years as a coordination and training officer with a foreign airline; on the board since March 2023.
Annual Report 2025-26, p.13SNSujit Nityanand ChakrabortyIndependent Director
Holds a Master of Computer Applications from IGNOU and an executive MBA in project management, with more than 25 years in information technology; chairs the board committees.
Annual Report 2025-26, p.13 and p.14NSNilay Shivnarayan SharmaIndependent Director
An engineering graduate of Shivaji University, Kolhapur, with more than 30 years in information technology.
Annual Report 2025-26, p.13Docmode Health Technologies latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- H2 FY26: sales ₹7.7 cr (-64%), net profit -₹0.1 cr (-) on H2 FY25.
- Shareholding, 31 March 2026: promoters 30.86% to 29.50%.
Docmode Health Technologies announcements
68 on record, latest first; each opens the filing on the exchange
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Certificate under SEBI (Depositories and Participants) Regulations, 2018PDF ↗
- Updates'Disclosure under Regulation 29(3) of the Securities and Exchange Board of India(Substantial Aquisition of Shares and Takeovers) Regulations, 2011 (Takeover CodPDF ↗
- Updates'Disclosure under Regulation 29(3) of the Securities and Exchange Board of India(Substantial Aquisition of Shares and Takeovers) Regulations, 2011 (Takeover CodPDF ↗
- Updates' Docmode Health Technologies Limited has informed the Exchange regarding 'Disclosure under Regulation 29(3) of the Securities and Exchange Board of India (SubsPDF ↗
- Disclosure under SEBI Takeover Regulationsof Disclosure under Regulation 29 (2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011PDF ↗
- Shareholders meetingSrutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting resultsPDF ↗
- Shareholders meetingProceedings of Annual General Meeting held on September 30, 2026PDF ↗
- Trading WindowClosure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF ↗
- Shareholders meetingNotice of Annual General Meeting to be held on September 30, 2026PDF ↗
- Outcome of Board Meeting, the financial results for the period ended March 31, 2026PDF ↗
- Trading WindowClosure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF ↗
- Amendment to AOA/MOAOf the companyPDF ↗
Docmode Health Technologies annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
Docmode Health Technologies share split, bonus and dividends
From the corporate actions the company announces on the exchange
No share split, bonus issue or dividend is on record since listing.
Checks we ran on Docmode Health Technologies' data · 9
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (31,42,800 shares).
- ✓The share capital in the FY26 results matches the share count in the shareholding pattern.
- ✓Promoter pledge figures are within possible limits in every shareholding pattern shown.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- ✓The two half-years of FY26 add up to the full-year sales.
- ✓Earnings per share moves in line with profit across the years shown.
- ✓Revenue and profit are reported for every year shown, FY20 to FY26.
- iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.
Questions people ask about Docmode Health Technologies
What does Docmode Health Technologies do?
Docmode Health Technologies, now renamed Doctrack Solutions, runs online and in-person courses, surveys and research programmes for doctors, paid for mostly by drug and healthcare companies. Its shares trade on NSE Emerge.
What is the share price of Docmode Health Technologies?
₹21.2 at the close on 4 Nov 2026, from the exchange's daily figures.
What is the market cap of Docmode Health Technologies?
₹7 cr at the close on 4 Nov 2026, on 31,42,800 shares.
What are Docmode Health Technologies' revenue and profit?
Revenue ₹26 cr and profit after tax -₹0 cr in FY26.
Who are the promoters of Docmode Health Technologies?
Paulson Paul Thazhathedath, Hans Albert Lewis; promoters held 29.50% at 31 March 2026.
What was the IPO price of Docmode Health Technologies?
₹79 a share; it listed on 2 Feb 2024.
What is Docmode Health Technologies' website?
www.docmode.org
More SME companies like Docmode Health Technologies
Other listed SME companies in other consumer services, the closest in size first, each read from its own documents.
- Kuberan Global Edu SolutionsKGES · BSE SME · Other Consumer ServicesMarket cap ₹7 cr
- Thinking Hats Entertainment SolutionsTHESL · NSE Emerge · Other Consumer Services · listed 2024Market cap ₹16 cr
- Humming Bird EducationHBEL · BSE SME · Other Consumer ServicesMarket cap ₹17 cr
- Safecure ServicesSAFECURE · BSE SME · Other Consumer ServicesMarket cap ₹24 cr
- Blue PebbleBLUEPEBBLE · NSE Emerge · Other Consumer Services · listed 2024Market cap ₹30 cr
- Ascensive EducareASCENSIVE · BSE SME · Other Consumer ServicesMarket cap ₹65 cr
Every listed SME company in Other Consumer Services → · SME companies listed in 2024 →
Built from 2 annual reports, 68 exchange announcements, 7 shareholding patterns and 7 years of reported results. Every figure carries its source; where the documents are silent, the page says so.